Navigation Links
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
Date:11/18/2011

ts in EYLEA.

The recommended dose for EYLEA is 2 mg administered by intravitreal injection every four weeks (monthly) for the first 12 weeks (3 months), followed by 2 mg once every eight weeks (2 months).  Although EYLEA may be dosed as frequently as 2 mg every four weeks (monthly), additional efficacy was not demonstrated when EYLEA was dosed every four weeks compared to every eight weeks.

There is a potential risk of arterial thromboembolic events (ATEs) following use of intravitreal VEGF inhibitors, including EYLEA, defined as nonfatal stroke, nonfatal myocardial infarction, or vascular death (including deaths of unknown cause).  The incidence of ATEs with EYLEA in clinical trials was low (1.8%).

Serious adverse reactions related to the injection procedure have occurred in less than 0.1% of intravitreal injections with EYLEA and include endophthalmitis, traumatic cataract, and increased intraocular pressure.

About the VIEW 1 and VIEW 2 Clinical StudiesThe safety and efficacy of EYLEA were assessed in two randomized, multi-center, double-masked, active-controlled studies in patients with wet AMD.  A total of 2412 patients were treated and evaluable for efficacy (1817 with EYLEA) in the two studies (VIEW 1 and VIEW 2). In each study, patients were randomly assigned in a 1:1:1:1 ratio to one of four dosing regimens: 1) EYLEA administered 2 mg every eight weeks following three initial monthly doses (EYLEA 2Q8); 2) EYLEA administered 2 mg every four weeks (EYLEA 2Q4); 3) EYLEA 0.5 mg administered every four weeks (EYLEA 0.5Q4); and 4) ranibizumab administered 0.5 mg every four weeks (ranibizumab 0.5Q4).  Patient ages ranged from 49 to 99 years with a mean of 76 years.

In both studies, the primary efficacy endpoint was the proportion of patients who maintained vision, defined as losing fewer than 15 letters of visual acuity at week 52 compared to baseline.  Data are available through week 52.
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
2. Regeneron Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes due October 1, 2016
3. Regeneron Ranked by Science Magazine as the #2 Employer in the Global Biopharmaceutical Industry
4. Regeneron Announces Clinical Presentations at ASRS 2011 Annual Meeting
5. Regeneron Reports Second Quarter 2011 Financial and Operating Results
6. Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
7. Trading in Regeneron Common Stock Halted
8. Regeneron Reports First Quarter 2011 Financial and Operating Results
9. Regeneron Announces Presentation at the Bank of America Merrill Lynch 2011 Health Care Conference
10. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion
11. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 27, 2015 As ... "Bionics Market - Global Industry Analysis, Size, Share, Growth, Trends ... at USD 7.96 billion in 2014, growing at a CAGR ... 20.49 billion in 2021. The global bionics market ... of accidents, which is leading to paralysis or amputation of ...
(Date:7/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/t63pbj/medical_device ) has announced ... Asia/Pacific Markets Seminar" conference to their offering. ... is well established, the next growth area is ... together with other countries in this region have all ... own medical device regulations. This seminar will provide a ...
(Date:7/27/2015)... 17, 2015 Research and Markets ( ... "G-Protein Coupled Receptors Market: Global Industry Analysis, ... 2022" report to their offering. ... based on of assay type, therapeutic area, and ... has been categorized into six major segments: cAMP ...
Breaking Medicine Technology:Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2G-Protein Coupled Receptors Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 2
(Date:7/28/2015)... Florida (PRWEB) , ... July 28, 2015 , ... ... America's trusted source for identifying Top Doctors, has based its selection process on ... the most outstanding in their medical specialties, in any area of medicine and ...
(Date:7/28/2015)... ... July 28, 2015 , ... Maryland Brain & Spine has ... along with it, more service offerings, updated treatment techniques, and additional state-of-the art online ... management and minimally invasive surgical treatment of brain and spine conditions. , “Adding ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Advanced Fertility ... organization’s inception in 2010, and Dr Dozortsev , a Reproductive Laboratory Director ... president. In 2012, he was succeeded by Dr Gianpiero Palermo, who is credited with ...
(Date:7/28/2015)... ... July 28, 2015 , ... The joint SCAN ... such as reducing high-risk medication use and improving compliance with diabetes treatment guidelines. ... behaviors and outcomes, this unique-in-the-industry Quality Network Program may be paving the way ...
(Date:7/28/2015)... ... 28, 2015 , ... American Sentinel University has been named ... for Geisinger Health System (GHS), one of the nation’s largest integrated health services ... with access to American Sentinel’s affordable, flexible and CCNE-accredited RN to BSN nursing ...
Breaking Medicine News(10 mins):Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 2Health News:Maryland Brain & Spine Announces New Specialty, New Name 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 4Health News:Advanced Fertility Center of Texas Is Proud to Announce That Our Lab Director Has Been Re-elected as The American College of Embryology President 2Health News:SCAN/Express Scripts MA Pharmacy Quality Network Program to be Featured in Upcoming AIS Webinar 2Health News:SCAN/Express Scripts MA Pharmacy Quality Network Program to be Featured in Upcoming AIS Webinar 3Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 2Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 3Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 4
... Novel protocol could provide new lung tissue for certain ... -- Belgian scientists who used embryonic stem cells to ... alternative to lung transplants for patients with chronic obstructive ... is the first time it,s been shown that embryonic ...
... ... BWIN™, and WaveRider® Product Lines , ... (PRWEB) November 6, 2009 -- WAV, Inc., the ... it has partnered with Vecima Networks Inc. (TSX:VCM), a leading provider of equipment ...
... of protests and arrests. , WASHINGTON, Nov. 6 ... Pelosi,s office for tearing up the "Health Care" bill. They ... and William Kee. , Hearing to be held at ... P.M., Friday, November 6, these five pro-life advocates will appear ...
... , PHILADELPHIA, Nov. 6 In a newly-published special ... hospital policies to prevent and treat venous thromboembolism (VTE), ... throughout the world. Lippincott Williams & Wilkins ... VTE, a disease that includes both the common medical ...
... Congressman Fattah releases the following statement in observance of Pancreatic ... is a rare and perplexing disease, yet it is the fourth ... year, more than 42,000 Americans will be diagnosed with the disease ... far too high. , "To find a cure for pancreatic ...
... role in boosting memories -- or forgetting them, researchers say ... remember the first time you smelled a type of flower? ... brain might. , In the study, published online Nov. ... objects to adult study participants. They paired the objects with ...
Cached Medicine News:Health News:WAV Distribution Partners with Vecima Networks Inc. 2Health News:WAV Distribution Partners with Vecima Networks Inc. 3Health News:Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism 2Health News:Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism 3Health News:New Smells 'Etched' in Brain: Study 2
... enzymatic cleaner is a fast-acting ... stubborn deposits in as little ... enzymatic cleaner contains an enzyme ... film on soft contact lenses ...
... These specialty Eraser instruments have been ... with the right tool for situations ... a series of 25 gauge intraocular, ... discrete treatment of target tissues for ...
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
Sterile cordless eraser tips, packsize is 10/box....
Medicine Products: